Teladoc Health Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Revenue	2,528	2,570	2,602	2,407	2,033	1,094
Revenue Growth (YoY)	-2.37%	-1.26%	8.13%	18.41%	85.81%	97.71%
Cost of Revenue	763.47	751.27	760.03	743.99	650.26	390.83
Gross Profit	1,765	1,818	1,842	1,663	1,382	703.13
Selling, General & Admin	1,301	1,346	1,367	1,301	1,105	886.88
Research & Development	283.07	307.27	348.52	333.63	311.88	164.94
Amortization of Goodwill & Intangibles	345.27	363.37	325.93	234.72	195.3	-
Operating Expenses	1,943	2,027	2,053	1,880	1,621	1,121
Operating Income	-178.59	-208.79	-210.5	-217.47	-238.99	-418.19
Interest Expense	-21.61	-23.8	-22.28	-21.94	-81.14	-59.95
Interest & Investment Income	44.05	57.07	46.78	12.67	0.78	-
Currency Exchange Gain (Loss)	-	-	-	-	-0.81	-
Other Non Operating Income (Expenses)	2.65	-6.04	4.45	-0.86	-	-0.55
EBT Excluding Unusual Items	-153.5	-181.56	-181.56	-227.6	-320.17	-478.68
Merger & Restructuring Charges	-24.82	-22.1	-38.05	-23.04	-26.64	-88.24
Impairment of Goodwill	-71.76	-790	-	-13,403	-	-
Gain (Loss) on Sale of Investments	-	-	-	-	5.9	-
Asset Writedown	-	-	-	-9.9	-	-
Other Unusual Items	-	-	-	-	-43.75	-9.08
Pretax Income	-250.08	-993.65	-219.61	-13,663	-384.66	-575.99
Income Tax Expense	-26.5	7.59	0.76	-3.81	44.14	-90.86
Net Income	-223.59	-1,001	-220.37	-13,660	-428.79	-485.14
Net Income to Common	-223.59	-1,001	-220.37	-13,660	-428.79	-485.14
Shares Outstanding (Basic)	175	171	165	161	157	91
Shares Outstanding (Diluted)	175	171	165	161	157	91
Shares Change (YoY)	3.59%	3.64%	1.93%	2.88%	73.40%	25.98%
EPS (Basic)	-1.28	-5.87	-1.34	-84.60	-2.73	-5.36
EPS (Diluted)	-1.28	-5.87	-1.34	-84.60	-2.73	-5.36
Free Cash Flow	280.11	282.89	338.56	172.81	185.46	-57.54
Free Cash Flow Per Share	1.60	1.66	2.06	1.07	1.18	-0.64
Gross Margin	69.80%	70.76%	70.80%	69.09%	68.01%	64.27%
Operating Margin	-7.06%	-8.13%	-8.09%	-9.04%	-11.76%	-38.23%
Profit Margin	-8.84%	-38.96%	-8.47%	-567.53%	-21.09%	-44.35%
Free Cash Flow Margin	11.08%	11.01%	13.01%	7.18%	9.12%	-5.26%
EBITDA	16.17	31.72	43.61	-7.54	-31.42	-354.49
EBITDA Margin	0.64%	1.23%	1.68%	-0.31%	-1.55%	-32.40%
D&A For EBITDA	194.76	240.51	254.11	209.93	207.57	63.69
EBIT	-178.59	-208.79	-210.5	-217.47	-238.99	-418.19
EBIT Margin	-7.06%	-8.13%	-8.09%	-9.04%	-11.76%	-38.23%
Advertising Expenses	-	693.21	673.55	609.45	397.77	199.15

Updated Oct 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q